CD4 and metastatic neoplasm: We stratified patients according to gender and M category and found that CD3ζ-chain expression on CD4+ T cells did not differ between males and females or between patients with limited (M1a/b) versus advanced (M1c) metastatic disease (Fig 1A, left plot).